top of page
  • Dil Singh

Cancer: 'Breakthrough'

All 14 patients went into remission in this ground breaking advancement in cancer research.

A new trial drug called dostarlimab is currently going through clinical trials, 14 patients have undergone the experiment with a 100% success rate! Researchers at Memorial Sloan Kettering cancer center in New York, found no signs of the cancer after numerous scans and physical assessments.

Read more about the ground breaking work that the Memorial Sloan Kettering Cancer Center have been carrying out here;



bottom of page